IVZ
52
-6
EQR
54
-3
MO
62
5
TEL
71
2
MRK
23
-5
SE
65
11
SNA
75
3
JNPR
56
-2
EXC
41
-2
WBA
48
-5
AEE
63
-3
MAT
41
-8
KEY
48
-2
AON
56
-2
BLK
72
-4
GOOG
79
2
HRB
60
-6
HP
41
-4
OI
45
-5
NUE
58
-6
IVZ
52
-6
EQR
54
-3
MO
62
5
TEL
71
2
MRK
23
-5
SE
65
11
SNA
75
3
JNPR
56
-2
EXC
41
-2
WBA
48
-5
AEE
63
-3
MAT
41
-8
KEY
48
-2
AON
56
-2
BLK
72
-4
GOOG
79
2
HRB
60
-6
HP
41
-4
OI
45
-5
NUE
58
-6
Financhill
Back

Aclaris Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
71

ACRS
Aclaris Therapeutics

Last Price:
2.44
Seasonality Move:
32.55%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Aclaris Therapeutics Price Quote

$2.44
-0.11 (-4.31%)
(Updated: November 13, 2024 at 5:55 PM ET)

Aclaris Therapeutics Key Stats

Buy
71
Aclaris Therapeutics (ACRS) is a Buy
Day range:
$2.34 - $2.59
52-week range:
$0.63 - $2.68
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.70
P/B ratio:
1.4%
Volume:
627.4K
Avg. volume:
828.8K
1-year change:
-46.37%
Market cap:
$181.9M
Revenue:
$31.2M
EPS:
$-0.52

How Much Does Aclaris Therapeutics Make?

Is Aclaris Therapeutics Growing As A Company?

  • What Is Aclaris Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.53%
  • What Is Aclaris Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Aclaris Therapeutics Stock Price Performance

What Is Aclaris Therapeutics 52-Week High & Low?

Aclaris Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aclaris Therapeutics?

Is Aclaris Therapeutics Cash Flow Positive?

  • What Is ACRS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.9M
  • What Is Aclaris Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $49K
  • What Is Aclaris Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $7.6M

Aclaris Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ACRS return on invested capital is -25.72%
  • What Is Aclaris Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -19.83%
  • What Is ACRS Return On Equity?
    ROE is a measure of profitability and is -25.72%

Aclaris Therapeutics Earnings Date & Stock Price

Aclaris Therapeutics Competitors

Aclaris Therapeutics Dividend Yield

Aclaris Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -1275%
Revenue: -53.18% -63.32%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 2.50
Downside from Last Price: -1.96%

Major Shareholders

  • How many ACRS shares are owned by institutional investors?
    67.8M ACRS shares are owned by institutional investors
  • How many ACRS shares are owned by insiders?
    3M ACRS shares are owned by insiders